The Impact of Age in Patients Undergoing Impella‐Assisted Percutaneous Coronary Interventions
Catheterization and Cardiovascular Interventions · 2025
DOI: 10.1002/ccd.31350 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Catheterization and Cardiovascular Interventions, 2025. Verfasst von Tia Bimal und 8 weiteren Autor:innen. Beteiligte Einrichtung: Northwell, New Hyde Park & Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York, USA. Hauptthemen laut MEDLINE: Heart-Assist Devices, Percutaneous Coronary Intervention, Shock, Cardiogenic, Coronary Artery Disease. Die Arbeit nennt 18 Literaturangaben.
Abstract (Originalsprache)
Background
Short‐term percutaneous mechanical circulatory support (MCS) devices provide hemodynamic support in cardiogenic shock or during high‐risk percutaneous coronary intervention (PCI).
Aims
To assess the impact of age on the clinical and angiographic characteristics and in‐hospital outcomes of all patients undergoing PCI with the Impella MCS.
Methods
Data on all patients that underwent PCI with an Impella was divided into three groups according to age: < 65, 65 to < 75 years, and ≥ 75 years. In‐hospital mortality, stroke, and major bleeding complications were assessed.
Results
Between 2010 and 2018, 245 patients underwent PCI with Impella support. Almost half of all patients were < 65 years old and 32% were ≥ 75 year old. Clinical characteristics varied significantly among the three groups. Almost half of younger patients were in the midst of an ST‐elevation myocardial infarction (STEMI) compared with 9% of patients ≥ 75 years ( p < 0.0001). Furthermore, 57% of younger patients were in cardiogenic shock, compared with 21% of those ≥ 75 years ( p = 0.002). In‐hospital mortality was highest in the 65 to < 75 years group (17%) compared with 9% and 10% in the < 65 and ≥ 75‐year‐olds groups, respectively. Major bleeding complications were not significantly different among the three age groups. Multivariable analysis for in‐hospital mortality showed that STEMI on presentation and ages 65 to < 75 years compared to those < 65 years were associated with an increased odds of in‐hospital death.
Conclusion
Clinical characteristics and indications for Impella MCS use in patients undergoing PCI varied significantly according to age. However, in‐hospital outcomes were not significantly different among the three groups.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Northwell, New Hyde Park & Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York, USA.
- Mather Hospital, Port Jefferson, New York, USA.
- Office of Academic Affairs Northwell Health, New Hyde Park, New York, USA.
- South Shore University Hospital, Bay Shore, New York, USA.
- North Shore University Hospital, Manhasset, New York, USA.
- Long Island Jewish Medical Center, New Hyde Park, New York, USA.
ORCID-Profile: Perwaiz M Meraj, Luis Gruberg
Zitieren
APA
Bimal, T., Fishbein, J., Gandotra, P., Meraj, P. M., Lee, A., Kim, M. C., Omar, W., Ong, L., & Gruberg, L. (2025). The Impact of Age in Patients Undergoing Impella‐Assisted Percutaneous Coronary Interventions. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.31350
Vancouver
Bimal T, Fishbein J, Gandotra P, Meraj PM, Lee A, Kim MC, et al. The Impact of Age in Patients Undergoing Impella‐Assisted Percutaneous Coronary Interventions. Catheterization and Cardiovascular Interventions. 2025. doi:10.1002/ccd.31350
BibTeX
@article{Bimal2025,
author = {Bimal, Tia and Fishbein, Joanna and Gandotra, Puneet and Meraj, Perwaiz M and Lee, Alexander and Kim, Michael C and Omar, Wally and Ong, Lawrence and Gruberg, Luis},
title = {The Impact of Age in Patients Undergoing Impella‐Assisted Percutaneous Coronary Interventions},
journal = {Catheterization and Cardiovascular Interventions},
year = {2025},
doi = {10.1002/ccd.31350}
}
EUVIMED